125 related articles for article (PubMed ID: 22646133)
1. Tioguanine in the treatment of refractory coeliac disease--a single centre experience.
Tack GJ; van Asseldonk DP; van Wanrooij RL; van Bodegraven AA; Mulder CJ
Aliment Pharmacol Ther; 2012 Aug; 36(3):274-81. PubMed ID: 22646133
[TBL] [Abstract][Full Text] [Related]
2. Commentary: tioguanine in the treatment of refractory coeliac disease.
Mooney PD; Sanders DS; Hadjivassilou M; Lennard L
Aliment Pharmacol Ther; 2012 Sep; 36(6):594-5; author reply 595. PubMed ID: 22913842
[No Abstract] [Full Text] [Related]
3. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
Herrlinger KR; Fellermann K; Fischer C; Kreisel W; Deibert P; Schoelmerich J; Fleig WE; Ruhl A; Reinshagen M; Greinwald R; Stange EF; Schwab M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1269-76. PubMed ID: 15191508
[TBL] [Abstract][Full Text] [Related]
4. Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies.
Simsek M; Deben DS; Horjus CS; Bénard MV; Lissenberg-Witte BI; Buiter HJC; van Luin M; Seinen ML; Mulder CJJ; Wong DR; de Boer NKH; van Bodegraven AA
Aliment Pharmacol Ther; 2019 Jul; 50(1):54-65. PubMed ID: 31094013
[TBL] [Abstract][Full Text] [Related]
5. On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment.
de Boer NK; de Graaf P; Wilhelm AJ; Mulder CJ; van Bodegraven AA
Aliment Pharmacol Ther; 2005 Sep; 22(5):447-51. PubMed ID: 16128683
[TBL] [Abstract][Full Text] [Related]
6. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
Almer SH; Hjortswang H; Hindorf U
Dig Liver Dis; 2009 Mar; 41(3):194-200. PubMed ID: 18799369
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
[TBL] [Abstract][Full Text] [Related]
8. Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study.
Pavlidis P; Ansari A; Duley J; Oancea I; Florin T
Inflamm Bowel Dis; 2014 Dec; 20(12):2239-46. PubMed ID: 25230165
[TBL] [Abstract][Full Text] [Related]
9. Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.
de Boer NK; Zondervan PE; Gilissen LP; den Hartog G; Westerveld BD; Derijks LJ; Bloemena E; Engels LG; van Bodegraven AA; Mulder CJ
Dig Liver Dis; 2008 Feb; 40(2):108-13. PubMed ID: 18083079
[TBL] [Abstract][Full Text] [Related]
10. Remission maintenance by tioguanine in chronic active Crohn's disease.
Herrlinger KR; Deibert P; Schwab M; Kreisel W; Fischer C; Fellermann K; Stange EF
Aliment Pharmacol Ther; 2003 Jun; 17(12):1459-64. PubMed ID: 12823147
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study.
Ciacci C; Maiuri L; Russo I; Tortora R; Bucci C; Cappello C; Santonicola A; Luciani A; Passananti V; Iovino P
Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1170-6. PubMed ID: 19473192
[TBL] [Abstract][Full Text] [Related]
12. Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.
de Boer NK; Derijks LJ; Keizer-Garritsen JJ; Lambooy LH; Ruitenbeek W; Hooymans PM; van Bodegraven AA; de Jong DJ
J Clin Pharmacol; 2007 Feb; 47(2):187-91. PubMed ID: 17244769
[TBL] [Abstract][Full Text] [Related]
13. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B
Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
[TBL] [Abstract][Full Text] [Related]
14. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease.
Kaukinen K; Peräaho M; Lindfors K; Partanen J; Woolley N; Pikkarainen P; Karvonen AL; Laasanen T; Sievänen H; Mäki M; Collin P
Aliment Pharmacol Ther; 2007 May; 25(10):1237-45. PubMed ID: 17451570
[TBL] [Abstract][Full Text] [Related]
15. High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.
van Egmond R; Chin P; Zhang M; Sies CW; Barclay ML
Aliment Pharmacol Ther; 2012 May; 35(10):1181-9. PubMed ID: 22486532
[TBL] [Abstract][Full Text] [Related]
16. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
17. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine.
Seiderer J; Zech CJ; Reinisch W; Lukas M; Diebold J; Wrba F; Teml A; Chalupna P; Stritesky J; Schoenberg SO; Schima W; Göke B; Ochsenkühn T
J Hepatol; 2005 Aug; 43(2):303-9. PubMed ID: 15964660
[TBL] [Abstract][Full Text] [Related]
18. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
Ferlitsch A; Teml A; Reinisch W; Ulbrich G; Wrba F; Homoncik M; Gangl A; Peck-Radosavljevic M; Vogelsang H
Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease.
Qasim A; McDonald S; Sebastian S; McLoughlin R; Buckley M; O'Connor H; O'Morain C
Scand J Gastroenterol; 2007 Feb; 42(2):194-9. PubMed ID: 17327939
[TBL] [Abstract][Full Text] [Related]
20. Letter: TPMT - not all that glitters is gold.
González-Lama Y; Gisbert JP
Aliment Pharmacol Ther; 2012 Jul; 36(2):208-9; author reply 209-10. PubMed ID: 22703467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
